RBLX:NYSERoblox Corporation Analysis
Data as of 2026-05-24 - not real-time
$48.16
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Roblox (RBLX) is trading at $48.16, comfortably above the computed support of $40.15 but well below the 200‑day SMA of $88.62, indicating a long‑term bearish backdrop. The 20‑day SMA ($46.76) sits just under the current price, while the 50‑day SMA ($53.08) remains a short‑term ceiling, and the RSI at 48.7 suggests neutral momentum. Technical signals are mixed: the MACD histogram is positive (0.76) signalling a modest bullish tilt, yet the overall trend is classified as bearish and volume is decreasing, underscoring heightened volatility (84% over 30 days) and a beta of 1.5. Fundamentals show robust revenue growth of 39% and strong operating cash flow ($1.98 B) with a healthy cash pile ($3.20 B), but margins are deep in the red (operating margin –16%, profit margin –21%) and debt‑to‑equity is extreme at 435, rendering the stock fundamentally risky. The DCF fair value of $61.78 implies a 34.6% upside, yet recent guidance cuts and a dramatic price‑target reduction from $165 to $48 reflect market skepticism.
Recent news is a split picture: while some analysts still label Roblox a “best buy” for growth, major houses such as Bank of America and Piper Sandler have slashed targets and moved to neutral, citing weakened bookings, mandatory age‑verification rollouts, and algorithm changes that may erode user engagement. The company continues to generate cash, but concerns over regulatory compliance and the sustainability of its growth model dominate the narrative. Given the undervaluation relative to DCF, strong cash generation, and platform network effects, the longer‑term outlook remains cautiously optimistic, provided the firm can stabilize bookings and navigate regulatory headwinds.
Recent news is a split picture: while some analysts still label Roblox a “best buy” for growth, major houses such as Bank of America and Piper Sandler have slashed targets and moved to neutral, citing weakened bookings, mandatory age‑verification rollouts, and algorithm changes that may erode user engagement. The company continues to generate cash, but concerns over regulatory compliance and the sustainability of its growth model dominate the narrative. Given the undervaluation relative to DCF, strong cash generation, and platform network effects, the longer‑term outlook remains cautiously optimistic, provided the firm can stabilize bookings and navigate regulatory headwinds.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price hovering near support with decreasing volume
- Mixed technical signals (positive MACD histogram vs bearish trend)
- Recent guidance cuts and price‑target reductions
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- DCF indicates ~35% upside
- Strong revenue growth and operating cash flow
- Undervalued price relative to fair value
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Platform network effects and expanding user base
- Large cash reserves to fund strategic initiatives
- Potential for margin improvement as monetization tools mature
Key Metrics & Analysis
Financial Health
Revenue Growth39.30%
Profit Margin-20.69%
P/E Ratio-39.8
ROE-311.94%
ROA-8.79%
Debt/Equity435.04
P/B Ratio86.5
Op. Cash Flow$2.0B
Free Cash Flow$1.2B
Industry P/E17.0
Technical Analysis
TrendBearish
RSI48.7
Support$40.15
Resistance$58.89
MA 20$46.76
MA 50$53.08
MA 200$88.62
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair Value$61.78
Target Price$64.81
Upside/Downside34.58%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta1.52
Volatility84.09%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.